In a meta-analysis of more than one million apparently healthy adult participants, elevated serum albumin levels were associated with a reduced risk of hypertension, adverse vascular events, all-cause mortality, certain cancers, and fracture, revealing serum albumin as a biomarker in determining the risk of adverse cardiometabolic outcomes [46]. This evidence concerns the gene ALB and hypertensive disorder.